Treating pancreatic tumours may have revealed a master switch for cancer. The discovery suggests a potential new approach to controlling cancer growth. Researchers identified a mechanism that could be targeted to stop tumour progression.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
GSK acquires Nuvalent for $10.6 billion to expand cancer portfolio